Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1975Cancer

3‐Bis(2‐chloroethyl)‐1‐nitrosourea(BCNU), cyclophosphamide, vincristine‐ and prednisone‐(BCOP): A new therapeutic regimen for diffuse histiocytic lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJohn DurantMassachusetts Institute of TechnologyVLVirgil LoebAmerican College of SurgeonsRDRonald F. DorfmanJikei University School of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Durant et al. (1975) studied this question.

synapsesocial.com/papers/6a1eeae65b601e8f2e050222https://doi.org/10.1002/cncr.2820360902
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potential for Prolonged Disease-free Survival Following Combination Chemotherapy of Non-Hodgkin’s Lymphoma1974 · 164 citations
  2. 2Clinical pharmacology and human antitumor activity of cytosine arabinoside1967 · 54 citations
  3. 3Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule1974 · 392 citations
  4. 4Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma1971 · 196 citations
  5. 5Malignant Lymphoma1973 · 106 citations